Tag: Anticoagulants
High Platelet Reactivity Tied to Ischemic, Bleeding Outcomes
Findings based on two-year follow-up after drug-eluting stent implantation
Idarucizumab Shows Reliable Reversal of Dabigatran
Effective for dabigatran reversal among patients with uncontrolled bleeding, undergoing urgent surgery
Review Questions Antithrombotic Tx in Essential Thrombocythemia
Findings inconsistent, imprecise for benefits/risks of antiplatelet tx; no extractable data on anticoagulants
Better Outcomes for Cardiology Care in Newly Diagnosed A-Fib
Reduction in stroke, death; increase in hospitalization for AF/SVT, MI
VKA Monotherapy Linked to Reduced MI, Stroke Risk in A-Fib
Vitamin K antagonist + acetylsalicylic acid dual therapy associated with increased bleeding risk
Value of Prolonged DAPT Varies With DAPT Score in PCI Patients
Reduced risk for ischemic events in patients with high scores receiving paclitaxel-eluting stents
Antiplatelet Bleeding Risk Higher Than Expected for Older Patients
Research suggests proton-pump inhibitors should be co-prescribed in patients age 75+ years
Many Taking NOACs for A-Fib May Not Be Getting Right Dose
Study of newer medications finds 16 percent receive too much or too little
Model Predicts Acute GI Bleeding in Anticoagulated Patients
New scoring model includes five factors predictive of GI bleeding in patients taking oral anticoagulants
Distinct Maternal, Fetal Risks for Anticoagulants in Pregnancy
VKA, LMWH tied to lowest risk of adverse maternal, fetal outcomes, respectively
